Non-alcoholic Fatty Liver Disease

"Non-alcoholic Fatty Liver Disease" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Fatty liver finding without excessive ALCOHOL CONSUMPTION.

Descriptor ID	D065626
MeSH Number(s)	C06.552.241.519
Concept/Terms	Non-alcoholic Fatty Liver Disease Non-alcoholic Fatty Liver Disease Non alcoholic Fatty Liver Disease NAFLD Nonalcoholic Fatty Liver Disease Fatty Liver, Nonalcoholic Fatty Livers, Nonalcoholic Liver, Nonalcoholic Fatty Livers, Nonalcoholic Fatty Nonalcoholic Fatty Liver Nonalcoholic Fatty Livers Nonalcoholic Steatohepatitis Nonalcoholic Steatohepatitis Nonalcoholic Steatohepatitides Steatohepatitides, Nonalcoholic Steatohepatitis, Nonalcoholic

Below are MeSH descriptors whose meaning is more general than "Non-alcoholic Fatty Liver Disease".

Diseases [C]
Digestive System Diseases [C06]
Liver Diseases [C06.552]
Fatty Liver [C06.552.241]
Non-alcoholic Fatty Liver Disease [C06.552.241.519]

Below are MeSH descriptors whose meaning is related to "Non-alcoholic Fatty Liver Disease".

Below are MeSH descriptors whose meaning is more specific than "Non-alcoholic Fatty Liver Disease".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Non-alcoholic Fatty Liver Disease" by people in this website by year, and whether "Non-alcoholic Fatty Liver Disease" was a major or minor topic of these publications.

Bar chart showing 36 publications over 10 distinct years, with a maximum of 6 publications in 2016

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2011	0	2	2
2013	0	2	2
2014	3	0	3
2015	5	0	5
2016	3	3	6
2017	2	2	4
2019	3	0	3
2020	4	0	4
2021	5	0	5
2022	2	0	2

Below are the most recent publications written about "Non-alcoholic Fatty Liver Disease" by people in Profiles.

Meza V, Arnold J, Díaz LA, Ayala Valverde M, Idalsoaga F, Ayares G, Devuni D, Arab JP. Alcohol Consumption: Medical Implications, the Liver and Beyond. Alcohol Alcohol. 2022 May 10; 57(3):283-291.

View in: PubMed
Stocks B, Gonzalez-Franquesa A, Borg ML, Björnholm M, Niu L, Zierath JR, Deshmukh AS. Integrated Liver and Plasma Proteomics in Obese Mice Reveals Complex Metabolic Regulation. Mol Cell Proteomics. 2022 Mar; 21(3):100207.

View in: PubMed
Yenilmez B, Wetoska N, Kelly M, Echeverria D, Min K, Lifshitz L, Alterman JF, Hassler MR, Hildebrand S, DiMarzio C, McHugh N, Vangjeli L, Sousa J, Pan M, Han X, Brehm MA, Khvorova A, Czech MP. An RNAi therapeutic targeting hepatic DGAT2 in a genetically obese mouse model of nonalcoholic steatohepatitis. Mol Ther. 2022 03 02; 30(3):1329-1342.

View in: PubMed
de Carvalho Ribeiro M, Szabo G. Role of the Inflammasome in Liver Disease. Annu Rev Pathol. 2022 01 24; 17:345-365.

View in: PubMed
Bala S, Ganz M, Babuta M, Zhuang Y, Csak T, Calenda CD, Szabo G. Steatosis, inflammasome upregulation, and fibrosis are attenuated in miR-155 deficient mice in a high fat-cholesterol-sugar diet-induced model of NASH. Lab Invest. 2021 12; 101(12):1540-1549.

View in: PubMed
Szabo G. Exosomes and MicroRNA-223 at the Intersection of Inflammation and Fibrosis in NAFLD. Hepatology. 2021 07; 74(1):5-8.

View in: PubMed
Miyata T, Wu X, Fan X, Huang E, Sanz-Garcia C, Ross CKC, Roychowdhury S, Bellar A, McMullen MR, Dasarathy J, Allende DS, Caballeria J, Sancho-Bru P, McClain CJ, Mitchell M, McCullough AJ, Radaeva S, Barton B, Szabo G, Dasarathy S, Nagy LE. Differential role of MLKL in alcohol-associated and non-alcohol-associated fatty liver diseases in mice and humans. JCI Insight. 2021 02 22; 6(4).

View in: PubMed
Tao L, Yi Y, Chen Y, Zhang H, Orning P, Lien E, Jie J, Zhang W, Xu Q, Li Y, Ding Z, Wu C, Ding Q, Wang J, Zhang J, Weng D. RIP1 kinase activity promotes steatohepatitis through mediating cell death and inflammation in macrophages. Cell Death Differ. 2021 04; 28(4):1418-1433.

View in: PubMed
Francque S, Szabo G, Abdelmalek MF, Byrne CD, Cusi K, Dufour JF, Roden M, Sacks F, Tacke F. Nonalcoholic steatohepatitis: the role of peroxisome proliferator-activated receptors. Nat Rev Gastroenterol Hepatol. 2021 01; 18(1):24-39.

View in: PubMed
Kwong AJ, Devuni D, Wang C, Boike J, Jo J, VanWagner L, Serper M, Jones L, Sharma R, Verna EC, Shor J, German MN, Hristov A, Lee A, Spengler E, Koteish AA, Sehmbey G, Seetharam A, John N, Patel Y, Kappus MR, Couri T, Paul S, Salgia RJ, Nhu Q, Frenette CT, Lai JC, Goel A. Outcomes of Liver Transplantation Among Older Recipients With Nonalcoholic Steatohepatitis in a Large Multicenter US Cohort: the Re-Evaluating Age Limits in Transplantation Consortium. Liver Transpl. 2020 11; 26(11):1492-1503.

View in: PubMed

People

Explore

Similar Concepts

Top Journals